Copy to clipboard 
GLW Medical offered a preview of its forthcoming GLW Sabre MIS bunion correction system, a guided instrumentation and implant platform. Limited market release is slated for the second half of 2026.
Sabre allows for percutaneous keyhole incisions designed to reduce postoperative pain and swelling, helps patients return to their active lives more quickly, and is built around a patent‑pending design. The system is engineered to enhance precision, efficiency, and consistency in minimally invasive distal metatarsal osteotomy.
Key features include:
- METATARSAL TRAJECTORY GUIDE: A stabilized outrigger and parallel pin guide architecture reduces parallax, aligning targeting pins to the metatarsal axis for controlled K-wire and implant trajectory.
- TRI PLANAR CORRECTION VISUALIZATION: A unique AP targeting arm and stacked pins confirm true AP imaging for accurate visualization of tri planar correction, enabling precise adjustment of distal metatarsal articular angle, lateral translation and rotation, and fixing the correction in one simple step.
- IMPLANT TARGETER: Purpose-aligned drill and screw guide interfaces maintain consistent implant paths without skiving, while cannulated, chamfered screws sit flush to minimize soft tissue irritation.
- PRESERVING MOBILITY: By avoiding joint fusion and limiting postoperative stiffness, the minimally invasive approach with highly controlled fragment manipulation may help reduce complications.
The system integrates GLW Medical’s Creed Edge patented ortholucent design, offering radiotranslucent properties that enhance visualization of bony structures during imaging. It pairs this with TriTip self‑drilling technology to deliver strong initial purchase, controlled cortical entry, and reliable self‑starting performance.
Each implant features a curved chamfered head that sits flush with the bone and incorporates the largest cannulation and K‑wire diameter per screw size on the market, reducing skiving and enabling smoother wire advancement. A constant thread pitch helps maintain alignment and prevent capital fragment rotation, while two proximally placed Creed Edge anchor implants provide cortical‑level strength and enhanced derotational stability. Together, they create a precise and reliable percutaneous fixation construct that supports consistent, reproducible results.
Source: GLW Medical
GLW Medical offered a preview of its forthcoming GLW Sabre MIS bunion correction system, a guided instrumentation and implant platform. Limited market release is slated for the second half of 2026.
Sabre allows for percutaneous keyhole incisions designed to reduce postoperative pain and swelling, helps patients return to their active lives...
GLW Medical offered a preview of its forthcoming GLW Sabre MIS bunion correction system, a guided instrumentation and implant platform. Limited market release is slated for the second half of 2026.
Sabre allows for percutaneous keyhole incisions designed to reduce postoperative pain and swelling, helps patients return to their active lives more quickly, and is built around a patent‑pending design. The system is engineered to enhance precision, efficiency, and consistency in minimally invasive distal metatarsal osteotomy.
Key features include:
- METATARSAL TRAJECTORY GUIDE: A stabilized outrigger and parallel pin guide architecture reduces parallax, aligning targeting pins to the metatarsal axis for controlled K-wire and implant trajectory.
- TRI PLANAR CORRECTION VISUALIZATION: A unique AP targeting arm and stacked pins confirm true AP imaging for accurate visualization of tri planar correction, enabling precise adjustment of distal metatarsal articular angle, lateral translation and rotation, and fixing the correction in one simple step.
- IMPLANT TARGETER: Purpose-aligned drill and screw guide interfaces maintain consistent implant paths without skiving, while cannulated, chamfered screws sit flush to minimize soft tissue irritation.
- PRESERVING MOBILITY: By avoiding joint fusion and limiting postoperative stiffness, the minimally invasive approach with highly controlled fragment manipulation may help reduce complications.
The system integrates GLW Medical’s Creed Edge patented ortholucent design, offering radiotranslucent properties that enhance visualization of bony structures during imaging. It pairs this with TriTip self‑drilling technology to deliver strong initial purchase, controlled cortical entry, and reliable self‑starting performance.
Each implant features a curved chamfered head that sits flush with the bone and incorporates the largest cannulation and K‑wire diameter per screw size on the market, reducing skiving and enabling smoother wire advancement. A constant thread pitch helps maintain alignment and prevent capital fragment rotation, while two proximally placed Creed Edge anchor implants provide cortical‑level strength and enhanced derotational stability. Together, they create a precise and reliable percutaneous fixation construct that supports consistent, reproducible results.
Source: GLW Medical
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
